project . 2016 - 2018 . Closed
VACTRAIN
Open Access mandate for Publications
European Commission
European Commission 692293 H2020-TWINN-2015
H2020 | CSA 999,475 EUR 999,475 EUR
Closed
Open Access mandate
No
Start a new DMP in Loading
Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda__h2020::69548d446abbac49db3007dfbc306f5d&type=result"></script>');
-->
</script> For further information contact us at helpdesk@openaire.eu
The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.